Myriad Genetics Inc (NASDAQ:MYGN)

34.27
Delayed Data
As of Apr 20
 -1.07 / -3.03%
Today’s Change
31.56
Today|||52-Week Range
42.50
+0.62%
Year-to-Date

Stock Price Forecast

The 16 analysts offering 12-month price forecasts for Myriad Genetics Inc have a median target of 34.00, with a high estimate of 50.00 and a low estimate of 25.00. The median estimate represents a -0.79% decrease from the last price of 34.27.

Analyst Recommendations

The current consensus among 21 polled investment analysts is to Hold stock in Myriad Genetics Inc. This rating has held steady since April, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.39
Sales
$183.2M
Reporting Date
May 05

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -1.70%
 
 
 
 
 
 
Growthannually -37.28%
 
 
 
 
 
 

Sales

Growthquarterly -0.66%
 
 
 
 
 
 
Growthannually -5.66%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account